Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration
Prokineticin-2 (PK2) is a secreted protein involved in a number of physiological functions. Here, the authors find that PK2 expression increases in surviving DA neurons from Parkinson's disease patients, and show it protects against dopaminergic degeneration in PD mouse models.
Saved in:
Main Authors: | Richard Gordon, Matthew L. Neal, Jie Luo, Monica R. Langley, Dilshan S. Harischandra, Nikhil Panicker, Adhithiya Charli, Huajun Jin, Vellareddy Anantharam, Trent M. Woodruff, Qun-Yong Zhou, Anumantha G. Kanthasamy, Arthi Kanthasamy |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/b8d6e03a18c04bd3a3c79b515e12e20f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury
by: Zhongyuan Bao, et al.
Published: (2021) -
Prokineticin receptor 2 affects GnRH3 neuron ontogeny but not fertility in zebrafish
by: Ivan Bassi, et al.
Published: (2020) -
Versatile Role of Prokineticins and Prokineticin Receptors in Neuroinflammation
by: Roberta Lattanzi, et al.
Published: (2021) -
PINK1 deficiency impairs adult neurogenesis of dopaminergic neurons
by: Sarah J. Brown, et al.
Published: (2021) -
Prokineticin 1–prokineticin receptor 1 signaling in trophoblast promotes embryo implantation and placenta development
by: Ewelina Goryszewska-Szczurek, et al.
Published: (2021)